Collaboration and Licensing Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Summarized Collaboration and Licensing Revenues

The following table summarizes the amounts recorded as revenue in the condensed consolidated statements of operations for each significant counterparty to a collaboration or licensing agreement for the three and nine months ended September 30, 2022 and 2021.

	Three Months Ended   September 30,				Nine Months Ended   September 30,
	2022		2021		2022		2021
Intrexon Energy Partners, LLC	$	3,768	—		$	3,768	$	—
Intrexon Energy Partners II, LLC	10,793		—		10,793		—
Castle Creek Biosciences, Inc.	—		18		—		371
Other	—		4		—		18
Total (1)	$	14,561	$	22	$	14,561	$	389

(1)Collaboration and licensing revenues recognized are associated with upfront and milestone payments which were previously deferred.

Summary of Deferred Revenue

Deferred revenue consisted of the following:

	September 30, 2022		December 31, 2021
Collaboration and licensing agreements	$	1,818	$	23,023
Prepaid product and service revenues	52		1,277
Other	24		213
Total	$	1,894	$	24,513
Current portion of deferred revenue	$	76	$	1,490
Long-term portion of deferred revenue	1,818		23,023
Total	$	1,894	$	24,513

Summary of Deferred Revenue by Collaborator